Sanofi entered into an exclusive agreement with Pune-based Emcure Pharmaceuticals for the distribution and promotion of its cardiovascular product portfolio in India. This strategic partnership aims to leverage the strengths of both companies to enhance access to Sanofi's well-established cardiovascular brands across the country. Under the terms of the agreement,...
Merck Licenses New Covid Treatment to 5 Indian Companies
Merck has inked pacts with multiple Indian companies: Cipla, Dr Reddy's Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals to license and produce a forthcoming treatment for Covid-19. The company, formally known as MSD, is in the process of developing molnupiravir in collaboration with Ridgeback Biotherapeutics. The investigational oral antiviral...
Emcure Pharmaceuticals, India, Acquires Ottawa company
Emcure Pharmaceuticals, a drug maker based in Pune in the western state of Maharashtra, has acquired Canada's International Pharmaceutical Generics Ltd. and its marketing arm Marcan Pharmaceuticals. Marcan Pharma has over 60 approved products mainly available from McKesson and Kohl & Frisch, among other wholesalers, reports Economic Times. Emcure recently...


